159 related articles for article (PubMed ID: 8321912)
1. Thromboxane A2/prostaglandin H2 receptors in streptozotocin-induced diabetes: effects of insulin therapy in the rat.
Morinelli TA; Tempel GE; Jaffa AA; Silva RH; Naka M; Folger W; Halushka PV
Prostaglandins; 1993 May; 45(5):427-38. PubMed ID: 8321912
[TBL] [Abstract][Full Text] [Related]
2. Characterization of thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptors of rat platelets and their interaction with TXA2/PGH2 receptor antagonists.
Hanasaki K; Arita H
Biochem Pharmacol; 1988 Oct; 37(20):3923-9. PubMed ID: 2973322
[TBL] [Abstract][Full Text] [Related]
3. Agonist-induced phosphorylation of human platelet TXA2/PGH2 receptors.
Okwu AK; Mais DE; Halushka PV
Biochim Biophys Acta; 1994 Mar; 1221(1):83-8. PubMed ID: 8130280
[TBL] [Abstract][Full Text] [Related]
4. Differential effect of pH on thromboxane A2/prostaglandin H2 receptor agonist and antagonist binding in human platelets.
Mayeux PR; Morinelli TA; Williams TC; Hazard ES; Mais DE; Oatis JE; Baron DA; Halushka PV
J Biol Chem; 1991 Jul; 266(21):13752-8. PubMed ID: 1830308
[TBL] [Abstract][Full Text] [Related]
5. Polymyxin B increases TXA2/PGH2 agonist and antagonist affinities in human platelet membranes.
Halushka PV; Boehm A; Mais DE
Eicosanoids; 1988; 1(1):41-4. PubMed ID: 2856171
[TBL] [Abstract][Full Text] [Related]
6. Decrease in agonist affinity for human platelet thromboxane A2/prostaglandin H2 receptors induced by a platelet-derived supernatant.
Dorn GW; Burch RM; Kochel PJ; Mais DE; Halushka PV
Biochem Pharmacol; 1987 Jun; 36(12):1913-7. PubMed ID: 2954555
[TBL] [Abstract][Full Text] [Related]
7. Desensitization of platelet thromboxane A2/prostaglandin H2 receptors by the mimetic U46619.
Liel N; Mais DE; Halushka PV
J Pharmacol Exp Ther; 1988 Dec; 247(3):1133-8. PubMed ID: 2974487
[TBL] [Abstract][Full Text] [Related]
8. The affinities of prostaglandin H2 and thromboxane A2 for their receptor are similar in washed human platelets.
Mayeux PR; Morton HE; Gillard J; Lord A; Morinelli TA; Boehm A; Mais DE; Halushka PV
Biochem Biophys Res Commun; 1988 Dec; 157(2):733-9. PubMed ID: 2974286
[TBL] [Abstract][Full Text] [Related]
9. Preoperative thromboxane A2/prostaglandin H2 receptor activity predicts early graft thrombosis.
Brothers TE; Robison JG; Elliott BM; Boggs JM
J Vasc Surg; 1998 Feb; 27(2):317-25; discussion 326-8. PubMed ID: 9510286
[TBL] [Abstract][Full Text] [Related]
10. Photoaffinity receptor antagonist for human platelet thromboxane A2/prostaglandin H2 receptors.
Mais DE; Liel N; Halushka PV
Biochem Pharmacol; 1990 Oct; 40(7):1457-61. PubMed ID: 2145838
[TBL] [Abstract][Full Text] [Related]
11. Androgen regulation of thromboxane A2/prostaglandin H2 receptor expression in human erythroleukemia cells.
Matsuda K; Mathur RS; Duzic E; Halushka PV
Am J Physiol; 1993 Dec; 265(6 Pt 1):E928-34. PubMed ID: 8279549
[TBL] [Abstract][Full Text] [Related]
12. Increased platelet thromboxane A2/prostaglandin H2 receptors in patients with pregnancy induced hypertension.
Liel N; Nathan I; Yermiyahu T; Zolotov Z; Lieberman JR; Dvilansky A; Halushka PV
Thromb Res; 1993 May; 70(3):205-10. PubMed ID: 8327985
[TBL] [Abstract][Full Text] [Related]
13. The cleavage of plasmenylethanolamine by phospholipase A2 appears to be mediated by the low affinity binding site of the TxA2/PGH2 receptor in U46619-stimulated human platelets.
Turini ME; Holub BJ
Biochim Biophys Acta; 1994 Jun; 1213(1):21-6. PubMed ID: 8011675
[TBL] [Abstract][Full Text] [Related]
14. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors.
Naka M; Mais DE; Morinelli TA; Hamanaka N; Oatis JE; Halushka PV
J Pharmacol Exp Ther; 1992 Aug; 262(2):632-7. PubMed ID: 1386885
[TBL] [Abstract][Full Text] [Related]
15. Labeling of human platelet plasma membrane thromboxane A2/prostaglandin H2 receptors using SQB, a novel biotinylated receptor probe.
Komiotis D; Wencel-Drake JD; Dieter JP; Lim CT; Le Breton GC
Biochem Pharmacol; 1996 Sep; 52(5):763-70. PubMed ID: 8765474
[TBL] [Abstract][Full Text] [Related]
16. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets.
Mais DE; Burch RM; Saussy DL; Kochel PJ; Halushka PV
J Pharmacol Exp Ther; 1985 Dec; 235(3):729-34. PubMed ID: 3001275
[TBL] [Abstract][Full Text] [Related]
17. Dissociation of the contractile and hypertrophic effects of vasoconstrictor prostanoids in vascular smooth muscle.
Dorn GW; Becker MW; Davis MG
J Biol Chem; 1992 Dec; 267(34):24897-905. PubMed ID: 1447225
[TBL] [Abstract][Full Text] [Related]
18. Subcellular localization of a thromboxane A2/prostaglandin H2 receptor antagonist binding site in human platelets.
Saussy DL; Mais DE; Baron DA; Pepkowitz SH; Halushka PV
Biochem Pharmacol; 1988 Feb; 37(4):647-54. PubMed ID: 2963640
[TBL] [Abstract][Full Text] [Related]
19. Glomerular thromboxane A2/prostaglandin H2 receptors: characterization and effect of adriamycin-induced nephrotic syndrome.
Mayeux PR; Shah SV
Biochim Biophys Acta; 1993 Apr; 1181(2):148-54. PubMed ID: 8481403
[TBL] [Abstract][Full Text] [Related]
20. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
Yin K; Halushka PV; Yan YT; Wong PY
J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]